RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.
ERS Genomics, co-founded by Dr. Emmanuelle Charpentier, a recipient of the 2020 Nobel Prize in Chemistry for her pioneering work on CRISPR/Cas9, provides access to the definitive patent portfolio for this groundbreaking technology.
/PRNewswire/ ERS Genomics Limited ( ERS ) is pleased to announce a new license agreement with Demeetra AgBio ( Demeetra ). This is a non-exclusive licensing.
/PRNewswire/ ERS Genomics Limited ( ERS ) is pleased to announce a new license agreement with Demeetra AgBio ( Demeetra ). This is a non-exclusive licensing.